Th2 Responses in OVA-Sensitized BALB/c Mice Are Down-Modulated By Mycobacterium bovis BCG Treatment
- First Online:
- 337 Downloads
This study aimed to determine whether Mycobacterium bovis Bacillus Calmette-Guérin (BCG) treatment can reverse an established allergic airway inflammation in a BALB/c mouse model of ovalbumin (OVA)-induced airway inflammation.
OVA sensitized BALB/c mice were challenged with aerosolized OVA on days 28 to 30, 34, 41 and 63. Mice were intranasal treated with BCG on days 35 and 42. Twenty-four hours after the last challenge, blood samples were collected to detect anti-OVA immunoglobulin isotypes, and bronchoalveolar lavage (BAL) was harvested for cell count. Additionally, lungs were collected for histological analysis, detection of the eosinophil peroxidase (EPO) activity and measurement of cytokines and CCL11. The expression of CTLA-4, Foxp3 and IL-10 was also determined in lung tissue by flow cytometry.
BCG treatment was able to inhibit an established allergic Th2-response, by decreasing the allergen-induced eosinophilic inflammation, EPO activity, levels of CCL11 and IL-4, serum levels of IgE and IgG1. Mycobacteria treatment increased lung levels of IFN-γ, IL-10 and TGF-β, and expressions of Foxp3 and CTLA-4 in CD4+T cells. Additionally, an increased production of IL-10 by CD8+ T cells was observed, even though no detectable changes in CD4+IL-10+ was noticed.
BCG treatment inhibits features of allergic airway inflammation and the results suggest that the mechanism underlying the down-regulatory effects of BCG on OVA-induced airway inflammation appear to be associated with the induction of both Th1 and T regulatory immune responses.
KeywordsAsthma allergic airway inflammation Mycobacterium bovis BCG IgE Th1/Th2 cytokines regulatory T cells
- 1.PJ B. Immunology of asthma and chronic obstructive pulmonary disease. Nature reviews Immunology. 2008;8(3):183-92. Epub 2008/02/16.Google Scholar
- 17.Alenmyr L, Matheu V, Uller L, Greiff L, Malm-Erjefalt M, Ljunggren HG, et al. Blockade of CTLA-4 promotes airway inflammation in naive mice exposed to aerosolized allergen but fails to prevent inhalation tolerance. Scandinavian journal of immunology. 2005;62(5):437–44. Epub 2005/11/25.PubMedCrossRefGoogle Scholar
- 21.Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2008;31(1):143–78. Epub 2008/01/02.CrossRefGoogle Scholar
- 22.Nahori MA, Lagranderie M, Lefort J, Thouron F, Joseph D, Winter N, et al. Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns. Vaccine. 2001;19(11–12):1484–95. Epub 2001/02/13.PubMedCrossRefGoogle Scholar
- 23.Ahrens B, Gruber C, Rha RD, Freund T, Quarcoo D, Awagyan A, et al. BCG priming of dendritic cells enhances T regulatory and Th1 function and suppresses allergen-induced Th2 function in vitro and in vivo. International archives of allergy and immunology. 2009;150(3):210–20. Epub 2009/06/06.PubMedCrossRefGoogle Scholar
- 25.Lagranderie M, Nahori MA, Balazuc AM, Kiefer-Biasizzo H, Silva JR L, Milon G, et al. Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production. Immunology. 2003;108(3):352–64. Epub 2003/02/27.PubMedCrossRefGoogle Scholar
- 27.Smart JM, Horak E, Kemp AS, Robertson CF, Tang ML. Polyclonal and allergen-induced cytokine responses in adults with asthma: resolution of asthma is associated with normalization of IFN-gamma responses. The Journal of allergy and clinical immunology. 2002;110(3):450–6. Epub 2002/09/05.PubMedCrossRefGoogle Scholar
- 29.Yokoi T, Amakawa R, Tanijiri T, Sugimoto H, Torii Y, Amuro H, et al. Mycobacterium bovis Bacillus Calmette-Guerin suppresses inflammatory Th2 responses by inducing functional alteration of TSLP-activated dendritic cells. International immunology. 2008;20(10):1321–9. Epub 2008/08/16.PubMedCrossRefGoogle Scholar
- 30.Christ AP, Rodriguez D, Bortolatto J, Borducchi E, Keller A, Mucida D, et al. Enhancement of Th1 lung immunity induced by recombinant Mycobacterium bovis Bacillus Calmette-Guerin attenuates airway allergic disease. American journal of respiratory cell and molecular biology. 2010;43(2):243–52. Epub 2009/10/07.PubMedCrossRefGoogle Scholar
- 39.Gao X, Bai H, Cheng J, Fan Y, Wang S, Jiao L, et al. CD8alpha+ and CD8alpha- DC subsets from BCG-infected mice inhibit allergic Th2-cell responses by enhancing Th1-cell and Treg-cell activity respectively. Eur J Immunol. 2012;42(1):165–75. Epub 2011/10/20.Google Scholar
- 40.Trandem K, Zhao J, Fleming E, Perlman S. Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J Immunol. 2011;186(6):3642–52. Epub 2011/02/15.Google Scholar
- 41.Renz H, Lack G, Saloga J, Schwinzer R, Bradley K, Loader J, et al. Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization. J Immunol. 1994;152(1):351–60. Epub 1994/01/01.Google Scholar
- 42.Thomas MJ, MacAry PA, Noble A, Askenase PW, Kemeny DM. T cytotoxic 1 and T cytotoxic 2 CD8 T cells both inhibit IgE responses. Int Arch Allergy Imm. 2001;124(1-3):187–9. Epub 2001/04/18.Google Scholar
- 43.Smith TR, Kumar V. Revival of CD8+ Treg-mediated suppression. Trends Immunol. 2008;29(7):337–42. Epub 2008/06/03.Google Scholar
- 44.Niederkorn JY. Emerging concepts in CD8(+) T regulatory cells. Curr Opin Immunol. 2008;20(3):327–31. Epub 2008/04/15.Google Scholar
- 45.Yamada A, Ohshima Y, Yasutomi M, Ogura K, Tokuriki S, Naiki H, et al. Antigen-primed splenic CD8+ T cells impede the development of oral antigen-induced allergic diarrhea. Allergy Clin Immun. 2009;123(4):889–94. Epub 2009/02/10.Google Scholar
- 46.Hamelmann E, Oshiba A, Paluh J, Bradley K, Loader J, Potter TA, et al. Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization. J Exp Med. 1996;183(4):1719–29. Epub 1996/04/01.Google Scholar
- 47.Stock P, Kallinich T, Akbari O, Quarcoo D, Gerhold K, Wahn U, et al. CD8(+) T cells regulate immune responses in a murine model of allergen-induced sensitization and airway inflammation. Eur J Immunol. 2004;34(7):1817–27. Epub 2004/06/24.Google Scholar